Evidence map›Paper›PMID 21098460›Full record

SynthesisCirculation2010

Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.

Theodore Mazzone

Abstract readMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Circulation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Therapeutic Potential ofPharmaceuticals (Basel, Switzerland) · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Theodore MazzoneDepartment of Medicine, University of Illinois at Chicago, 60612, USA. tmazzone@uic.edu
University of Illinois Chicago · US

Funding

MACROPHAGE CHOLESTEROL METABOLISM AND APO-E SYNTHESISR01HL039653 · UNIVERSITY OF ILLINOIS AT CHICAGO · 1988 to 2005
$1.6M
Adipocyte Lipid Metabolism and ApoE ExpressionR56DK071711 · UNIVERSITY OF ILLINOIS AT CHICAGO · 2005 to 2005
$116k
NCRR NIH HHS UL1 RR029879NCRR NIH HHS UL1RR029879NHLBI NIH HHS HL39653NHLBI NIH HHS R01 HL039653NIDDK NIH HHS DK71711NIDDK NIH HHS R01 DK071711NIDDK NIH HHS R56 DK071711
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBlood GlucoseDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic AngiopathiesHumansHyperglycemiaHypoglycemic AgentsMorbidityRandomized Controlled Trials as TopicRisk FactorsBlood GlucoseHypoglycemic Agents

Identifiers

PMID21098460
PMCPMC3005220
OpenAlexW2020305323

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.